Beckers Hospital Review
JULY 9, 2025
The post Pharmacy groups call on insurers to preserve vaccine coverage appeared first on Becker's Hospital Review | Healthcare News & Analysis. The groups emphasized that the scientific consensus supporting vaccinations as essential tools for disease prevention remains unchanged. .”
Beckers Hospital Review
JULY 8, 2025
To evaluate how baseline steroid use can affect immune checkpoint inhibitor therapy, researchers analyzed clinical outcomes of 277 patients with non-small cell lung cancer. and 189 at the University of Southern California in Los Angeles who received immune checkpoint inhibitor therapy, 21 were taking steroids at the start of ICI therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 16, 2025
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.
Beckers Hospital Review
JULY 2, 2025
During a featured session at Becker’s Hospital Review 15th Annual Meeting in April, Eli Tarlow, a healthcare strategist and director with the tech firm CDW, took the stage to confront a sobering reality: health systems must be prepared to deliver care without technology — for as long as a month.
Pharmacy Times
JUNE 24, 2025
Author(s): Alexandra Gerlach, Associate Editor , Scott A.
Pharmacy Times
JUNE 20, 2025
Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.
Pharmacy Times
JULY 16, 2025
Further, the incidence, severity, and kinetics of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome with CD20 × CD3 TCEs may vary depending on the B-cell lymphoma subtype and the combination partners used, which is a notable consideration for oncology pharmacists when operationalizing these therapies.
Expert insights. Personalized for you.
93 
Let's personalize your content